Yu Liu, Chen Ke, Xu Ying, Wang Shubei, Liu Qianqian, Ye Qiao, Ye Tingjun, Sun Yunwei
Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Infectious Disease, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Hematol Oncol. 2017 Sep;35(3):303-309. doi: 10.1002/hon.2298. Epub 2016 May 3.
Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (EUS-FNA) have a great value in clinical practice of gastrointestinal lymphoma (GIL). Auxiliary methods such as flow cytometry (FCM) and gene rearrangement provide additional information for the diagnosis. Current study aims to explore the diagnostic value of EUS-FNA combined with FCM and gene rearrangement for GIL in our single institution. Suspected GIL cases, which were referred to EUS, FNA, FCM, or gene rearrangement examination, were retrospectively reviewed from January 2011 to May 2014. Definitive final diagnosis was included based on the pathological and immunostaining evidence. The gene scan analysis was applied for fragment detection in gene rearrangement. The sensitivity, specificity, and accuracy were considered and calculated. Fifty-three EUS cases were identified, including 38 GIL, 10 inflammations, 4 linitis plastica, and one multiple myeloma. EUS-FNA was successfully conducted in 39 out of 53 cases. After combined with FCM, the sensitivity, specificity, and accuracy were increased from 60.7% to 76.9%, 90.9% to 100%, and from 69.2% to 81.8% respectively. Among 33 cases for FCM, 11 of them gained positive B or T non-Hodgkin lymphoma diagnosis, and 28 out of 53 specimens were delivered for gene rearrangement. The sensitivity, specificity, and accuracy of gene rearrangement were 68.2%, 100%, and 75% respectively. EUS-FNA is a possible technique for the diagnosis of GIL, With additional FCM examination may further improve the diagnostic efficiency and facilitate subclassification. Moreover, gene rearrangement assay by gene scan is also a considerable method in the specimens from GIL. Copyright © 2016 John Wiley & Sons, Ltd.
内镜超声(EUS)及EUS引导下细针穿刺抽吸术(EUS-FNA)在胃肠道淋巴瘤(GIL)的临床实践中具有重要价值。诸如流式细胞术(FCM)和基因重排等辅助方法可为诊断提供更多信息。本研究旨在探讨在我们单中心机构中EUS-FNA联合FCM及基因重排对GIL的诊断价值。回顾性分析了2011年1月至2014年5月间接受EUS、FNA、FCM或基因重排检查的疑似GIL病例。最终确诊基于病理及免疫染色证据。基因扫描分析用于基因重排中的片段检测。计算并考量了敏感性、特异性及准确性。共确定53例EUS病例,其中包括38例GIL、10例炎症、4例皮革胃及1例多发性骨髓瘤。53例中有39例成功进行了EUS-FNA。联合FCM后,敏感性、特异性及准确性分别从60.7%提高至76.9%、90.9%提高至100%、69.2%提高至81.8%。在33例接受FCM检查的病例中,11例获得B或T非霍奇金淋巴瘤阳性诊断,53份标本中有28份进行了基因重排。基因重排的敏感性、特异性及准确性分别为68.2%、100%及75%。EUS-FNA是诊断GIL的一种可行技术,额外的FCM检查可进一步提高诊断效率并有助于进行亚分类。此外,基因扫描的基因重排检测在GIL标本中也是一种重要方法。版权所有© 2016约翰威立父子有限公司。